Clinical trial
Low-dose Aspirin Therapy in Patients With Non-Cardioembolic Ischemic Stroke and Microbleeds
NCT04504864 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low-dose Aspirin Therapy in Patients With Non-Cardioembolic Ischemic Stroke and Microbleeds
- Lead sponsor
- Xijing Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 1, 2020
- Completion date
- August 31, 2022
- Enrollment
- 400 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.